In rats, the increase in heart mass during normal growth is accompanied by a marked increase in the concentration of monamine oxidase (MAO). Similarly, cardiac hypertrophy resulting from experimental hypertension (induced either by desoxycorticosterone acetate (DOCA) and sodium or by renal artery stenosis) is also associated with a pronounced increase in MAO concentration. Conversely, the delayed growth of the heart occurring during sodium restriction is accompanied by a lower MAO activity. These changes in MAO, independent of the cause, appear closely related to the mass of the heart. However, the reduction in norepinephrine storage observed in the heart and other tissues of rats made hypertensive with DOCA and sodium cannot be explained by the changes in the concentration of MAO. The MAO activity of other tissues of the hypertensive rats is similar to that in the tissues of normal rats, with the exception of the kidney in which the MAO concentration is reduced. The subcellular distribution of MAO is similar in hypertensive and control rats. In both groups, the MAO is mainly localized in the mitochondrial fraction of the liver. In contrast, in the heart, the major fraction of MAO activity is found in the microsomal fraction.
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• Previous studies have indicated that animals made hypertensive by desoxycorticosterone acetate (DOCA) and sodium showed a decrease retention of norepinephrine in the storage granules of the sympathetic nerve in the heart and in several other tissues (1) (2) (3) . This stimulated further investigation of the catabolism of norepinephrine. Monamine oxidase (MAO) and catechol-O-methyl transferase (COMT), the two major enzymes responsible for the metabolism of norepineph- Accepted for publication July 7, 1968. rine, were studied in the heart and other organs of hypertensive rats. This report shows that MAO activity increased markedly in the hypertrophied heart of hypertensive rats. The increased MAO activity in these hearts appears to be related to the increase in cardiac mass rather than to the change in storage of norepinephrine associated with the development of hypertension.
Methods
Male Sprague-Dawley rats were used in all the studies. Hypertension was produced either by DOCA and sodium as previously described (3) or by renal artery stenosis after removal of the right kidney and ligature of the left renal artery over a no. 22 stylet. Sodium depletion was achieved by giving the rats a synthetic diet deficient in sodium (Nutritional Biochemicals, Cleveland, Ohio). The systolic blood pressure was measured on the tail of unanesthetized rats with a pulse transducer (2, 3 ) .
For the enzyme assays, the tissues were homogenized in 25 to 50 volumes of ice-cold iso-Circulation Research, Vol. XXIII, September 1968 362 DE CHAMPAIN, KRAKOFF, AXELROD tonic sucrose (0.25M). MAO was assayed by two methods using either 14 C-tryptamine or 14 Cnorepinephrine as substrate. With 34 C-tryptamine, the formation of 14 C-indoleacetic acid was measured according to the method developed by Wurtman and Axelrod (4) . One mg of heart, gut, kidney, and aorta and 0.5 mg of liver were used. With 14 C-d/-norepinephrine as a substrate, the formation of dihydroxymandelic acid was measured. For the latter assay, 5 mg of tissue were incubated for 30 minutes at .37 °C at pH 7.4 with 14 C-norepinephrine (4.25 m//.moles) in a total volume of 0.3 ml. At the end of the incubation, the reaction was stopped with 0.2 ml of 2N hydrochloric acid. The mixture was then extracted with 6 ml of ethyl acetate (water saturated) in the presence of an excess of NaCl. by agitation for 15 minutes. An aliquot of 4 ml of the organic phase was analyzed for radioactivity in a liquid scintillation spectrometer after the addition of 1 ml of ethanol and 10 ml of toluene phosphor. Unless specified, tryptamine was used as a substrate.
COMT activity was examined on aliquots of the supernatant liquid obtained after centrifugation of the homogenate for 10 minutes at 8000 g. The enzyme was assayed by measuring the formation of 14 C-normetaneplirine on incubation with Z-norepinephrine and 14 C-methyl-S-adenosylmethionine (Specific activity 50 mc/ mmole, New England Nuclear) as previously described by Axelrod (5) . The MAO and COMT activity are expressed in m^imoles of product formed per milligram of wet weight during 1 hour of incubation at 37°C.
The subcellular distribution of MAO in the heart and liver was studied by differential centrifugation. The tissues were homogenized at 0°C in isotonic sucrose, and subsequent centrifugations were carried on at 0°C. The nuclei, unbroken cells, and cellular debris were removed by a preliminary centrifugation at 600 g for 10 minutes. The mitochondria were obtained by a subsequent centrifugation at 12,000 g for 10 minutes, and the microsomal fraction was obtained by a final centrifugation at 105,000 g for 1 hour. The remaining high speed supernatant fraction was also analyzed for MAO activity.
Tritiated and endogenous norepinephrine were measured in tissues as previously described (6) (7) (8) .
Results

MAO and COMT in Tissues of
Hypertensive Rats.-MAO and COMT were measured in hearts and livers of hypertensive rats treated with DOCA and sodium for 6 weeks ( Table 1 ). The cardiac mass of the hypertensive animals increased by about 25%, and the MAO activity rose significantly per unit weight. These changes were also associated with a decrease in the retention of 3 Hnorepinephrine, 1 hour after 8 H-norepinephrine was injected intravenously, and with a 9.8 11.5 ± 5.9 ±37 ± 5.9* ± 0.08 ± 0.5 ± 0.8 ± 0.5* Rats were treated for 6 weeks with DOCA, 10 mg/week, or were given 1% saline to drink, or both. The rats were injected with 25 /xc of tritiated norepinephrine (5c/mmole) via the tail vein and were killed 1 hour later. The activity of MAO and COMT are expressed in m,umoles of product formed per mg of tissue dining 1 hour of incubation at37°C. Each group contains seven to eight rats. The results are given as the mean ± SEM.
*i>< 0.001; fP<0.01; $P<0.05 compared to control values. reduction in endogenous concentration and content of the heart as previously reported (2) . In the same hearts, the COMT activity was slightly reduced. In the livers from hypertensive rats, MAO and COMT activities were similar to control values. In the hearts of rats given either 1% saline or DOCA for 6 weeks, no significant changes were observed in the activity of these two enzymes.
In the livers of the same rats, the MAO activity was slightly reduced.
In another study, one group of rats was treated with DOCA and sodium for 4 weeks and another group was subjected to sodium restriction for 2 weeks. The MAO activity was examined in the heart and several other tissues ( Table 2 ). The hearts from the hypertensive rats were hypertrophied by 14% while those from the sodium-restricted rats were 25$ smaller. The MAO concentration was increased in the hypertrophied heart, whereas it was decreased in the smaller Each group contained six to eight rats. Tryptamine was used as substrate for all tissues studied. In the heart, both tryptamine and norepinephrine were used.
MAO activity is expressed in m/imoles of product formed per hour of incubation per mg of tissue. When norepinephrine is used as substrate in the heart, the results are expressed in counts/min of product formed per mg of tissue after 30 minutes of incubation. A group of rats was treated for 4 weeks with subcutaneous injections of DOCA, 10 mg/week, and given 1% saline to drink. A synthetic, sodium-deficient diet (Nutritional Biochemicals, Cleveland, Ohio) was given for 2 weeks to another group of rats (Low Na Diet). At the end of the treatment, the animals were injected with 25 /xc of tritiated norepinephrine and were killed 4 hours later.
*P < 0.001; t P < 0.05; *P < 0.01 compared to control values.
Monoamine Oxidase (MAO)
Group Control Nonhypertensive Hypertensive The rats were made hypertensive by constriction of the left renal artery and right nephrectomy. The nonhypertensive group refers to the operated rats which did not develop hypertension.
The study was made 4 weeks after the operation. The means are given ±SEM.
*P < 0.01; fP < 0.05 compared to control rats.
hearts from the sodium-restricted group. When either norepinephrine or tryptamine was used as substrate for MAO, similar results were obtained in the heart. In other tissues, such as intestine, aorta, or tail artery, the MAO activity of the hypertensive rats was not different from that found in tissues from control rats. In the kidney of the hypertensive rats, the MAO concentration was significantly reduced. The increased MAO activity was not limited to the cardiac hypertrophy associated with DOC A and sodium hypertension but could also be observed in the cardiac hypertrophy associated with renal hypertension ( Table 3 ). In these rats the heart weight increased by 47% while the MAO activity increased 41% per unit weight of heart. The rats that did not become hypertensive after operation had a normal MAO activity and no significant increase in heart weight. Changes in MAO and Endogenous Norepinephrine during Heart Growth.-To determine whether the concentration of MAO also increases during the normal growth of the heart, normal rats were studied at various ages (Fig. 1) . The hearts of the heaviest rats weighed about three times more than those of the smallest rats. Between the two extreme groups the MAO concentration of the heart increased about fivefold, and the total cardiac MAO increased fifteenfold. Despite this increase in MAO activity, the endogenous norepinephrine content and concentration of the same hearts increased during cardiac growth (Fig. 2) . The MAO concentration of the liver remained unchanged in the same groups of animals.
Dissociation between MAO Activity and Norepinephrine Storage in the Heart.-The MAO activity of the hearts of hypertensive rats was increased when compared to that of the hearts of controls of the same weight (approximately 250 g). However, the MAO activity of the hearts of hypertensive rats was the same as the control when compared Norepinephrine content and concentration in the hearts of the same animals studied in Figure 1 . Relationship between heart weight, MAO activity, and norepinephrine content of hypertrophied hearts from hypertensive rats and hearts from control rats weighing 350 g. Results are expressed as % change from the rats weighing 250 g which were the age-matched controls for the hypertensive animals. The figure shows the means for 8 normal rats weighing 350 g and for 50 hypertensive animals. The heart weight, MAO activity, and norepinephrine content of these two groups of rats were significantly different from the rats weighing 250 g.
with normal hearts of comparable size from larger rats (weighing 350 g) ( Fig. 3 ). Both the hearts from the hypertensive rats and those from the larger control rats were 20 to 25$ bigger than the heart of the 250-g control rats. In both types of enlarged hearts, the MAO activity was markedly increased to the same extent. However, despite increased MAO, the endogenous norepinephrine content of the larger hearts from controls weighing 350 g was elevated 40%, and the norepinephrine content of the hypertrophied hearts was reduced by 25%. When hypertensive rats were treated with a long-lasting ganglionic blocking agent (chlorisondamine), the storage of tritiated norepinephrine in the hearts from hypertensive rats returned to normal levels without any change in the concentration of MAO (Table 4 ). These and the preceding findings show a dissociation between MAO activity and the norepinephrine levels or the storage of tritiated norepinephrine in the heart.
Subcellular Distribution of MAO in Heart and Liver-The subcellular distribution of MAO was studied by differential centrifugation in the liver and the heart of hypertensive and control rats. No significant difference could be observed between the subcellular distribution of the MAO activity in the tissues from the hypertensive or control rats (Fig. 4) . In the liver, the MAO activity was localized mainly in the mitochondria] fraction, whereas in the heart, the greatest activity was localized in the microsomal fraction. The rats were injected with 25 /xc of 3 H-norepinephrine via the tail vein 15 minutes before starting the treatment with chlorisondamine (10 mg/kg every 8 hours) and they were killed 24 hours later. The means are given ± SEM. *P < 0.001; fP < 0.01 compared to control in each group. There was no significant difference in the activity found in each fraction between the hypertensive and control rats.
Kinetics of MAO in Hearts from Control and Hypertensive Rats.-To determine whether the increased MAO concentration in the hy-
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pertrophied hearts was due to the synthesis of a different type of MAO, the Michaelis-Menton constant (Km) and maximum velocity (V limx ) of that enzyme were studied with and without a competitive MAO inhibitor N-methyl-N-2-Propynyl-Benzylamine hydrochloride (Pargyline) ( Fig. 5 and Table 5 ). Without inhibitor, the Km for MAO in the hearts of control rats was almost identical to that in the hearts of hypertensive rats. However, the V max was higher in the hypertrophied hearts from hypertensive rats, consistent with an increase in the concentration of the enzyme. Similar findings were observed after inhibition of the enzyme with Pargyline at the concentration
Discussion
The present studies demonstrate that cardiac hypertrophy resulting from experimental hypertension in the rat is associated with a marked increase in MAO activity. Conversely the concentration of MAO is reduced in the smaller hearts of the sodium-restricted rats. It appears that these changes in the concentration of MAO are related to the growth processes of the heart. During normal growth, there is a progressive and marked increase in the concentration of MAO in the heart.
MAO activity has been previously reported to increase with age in the rat hearts (9) (10) (11) (12) . However, our findings indicate that, during cardiac hypertrophy, cardiac mass, rather Lineweaver-Burk plots of MAO activity in hearts from hypertensive and control animals with and without the addition of an MAO inhibitor (Pargyline 10-'IM). 1/S is given as 1/M X 10~s and 1/V is the reciprocal of m/imoles of product/hour/mg of wet weight. The Km, V , and the slope, as well as the statistical significance, are given in Table 5 .
than age, is the major factor related to MAO concentration. Hypertension, DOCA, or sodium by themselves do not play an important role in inducing the increase in MAO activity since this phenomenon was confined to the heart and could not be detected in other tissues of the hypertensive rats, such as the liver, intestine, kidney, and arterial tissue. It appears that the changes in cardiac MAO are related to changes in cardiac mass regardless of the factors that influence heart growth.
In the present, as well as in previous studies (1-3), the storage of endogenous and exogenous norepinephrine was reduced in the heart and in several other tissues of rats made hypertensive by the administration of DOCA and sodium. It was suggested that, in this form of hypertension, less norepinephrine is inactivated by the mechanisms of uptake and storage by the nerve and more of the Circulation Research, Vol. XXIII, September 1968 amine is available to react with the receptors. However, the increased MAO found in the hypertrophied hearts of these rats suggest that an increased deamination of norepinephrine by MAO might be the likely explanation for the reduction in the storage of the catecholamines. Nevertheless, several observations argue against such an explanation. For instance, the MAO activity does not appear to bear any relationship with the cardiac norepinephrine storage capacity in normal rats. During the normal growth of the heart, there is a continuous increase in the cardiac norepinephrine content despite the progressive increase in the MAO concentration. Moreover, the capacity of the hearts of hypertensive rats to retain and store tritiated norepinephrine can be restored to normal levels by treatment with a ganglionic blocking agent without any change in the cardiac MAO. Finally, the reduced norepinephrine storage also found in the intestine, kidney, spleen, and skeletal muscle of the hypertensive rats cannot be explained by changes in the MAO activity.
The study of the kinetics of MAO from hypertrophied hearts shows that the Km is similar to that of the MAO in the agematched control rats. These findings suggest that the increase in MAO is not due to the synthesis of a different form of MAO, but that it is probably due to an increased concentration of the existing enzyme(s).
MAO has been reported to be localized mainly in the mitochondria of the liver (13-16), brain (17) (18) , and adrenal (19) . The study of the subcellular distribution of MAO in the heart is of special interest since the concentration of other mitochondrial enzymes such as succinic dehydrogenase and cytochrome oxidase was found to remain unchanged during heart growth (11) . Moreover, the subcellular distribution of MAO might have been changed during the development of cardiac hypertrophy. Our studies show that the subcellular distribution of MAO is similar in the control and the hypertensive rats. In agreement with previous studies, MAO was mainly associated with the mitochondrial fraction of the liver. In contrast, MAO appeared to be localized in lowerdensity particles in the heart. Most of the MAO activity was associated with the microsomal fraction, and only 25% of the activity was found with the mitochondria. Further studies, using continuous sucrose gradient, have confirmed the main localization of MAO in the heart in smaller particles migrating in close association with the norepinephrine storage granules (20) . Moreover, a complete dissociation could be demonstrated between the subcellular distribution of cytochrome oxidase and that of MAO. The different distribution of MAO in the heart indicates that the localization of enzyme can vary between various organs and that this may reflect different metabolic functions.
In summary, cardiac MAO activity in the rat is uniquely related to cardiac enlargement whether it is due to normal growth or due to induced hypertrophy. The changes in tissue catecholamine storage and metabolism observed in DOCA and sodium hypertension, however, appear unrelated to tissue MAO activity.
